Interview: Responses to new psychoactive substances in sexual health settings

Information on health responses to the use of new psychoactive substances (NPS) is emerging but, in many cases, remains anecdotal.

Originally published in:

Health responses to new psychoactive substances (Perspectives on Drugs)

Related:

Interview: Responses to new psychoactive substances in nightlife settings

Main subject

drug harms

Keywords

health harms of drug use
hepatitis C
HIV
drug-related infectious diseases
MSM
NPS
sexual health

Media type:

video

Published date:

June 2016
CC-BY-4.0
Watch on YouTube

Related assets in the Media library

Screenshot from the webinar on the past and present of methamphetamine
EMCDDA webinar: Methamphetamine in Europe — past and present
Infographic: Number of acute drug toxicity presentations with mention of cannabis in 10 selected hospitals during the first three quarters of 2019 and 2020
graphic figure 15
Infographic: Outcome of presentation (left) and length of hospital stay (right), Euro-DEN Plus presentations, 2014-17
graphics figure 12
Infographic: Gender and main drugs involved in the presentations in selected centres, Euro-DEN Plus, 2017
graphic figure 10
infographic: Top 20 prescription medicines involved in ‘any prescription medicine’ presentations (left) and ‘prescription medicine only’ presentations (right), Euro-DEN Plus, 2014-17
graphic
Infographic: Frequency distribution of the main drug groups among all drugs identified in Euro-DEN Plus presentations, 2014-17

Media library

Loading